Literature DB >> 4281061

Postmortal accumulation of 3-methoxytyramine in brain.

A Carlsson, M Lindqvist, W Kehr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4281061     DOI： 10.1007/bf00504705

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  6 in total

1.  Individual elution of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from a single, strong cation exchange column, by means of mineral acid-organic solvent mixtures.

Authors:  C V Atack; T Magnusson
Journal:  J Pharm Pharmacol       Date:  1970-08       Impact factor: 3.765

2.  Post-mortal changes of dopamine and homovanillic acid levels in rat striatum as measured by mass fragmentography.

Authors:  F A Wiesel; G Sedvall
Journal:  Brain Res       Date:  1974-01-18       Impact factor: 3.252

3.  A method for the isolation and determination of 3-methoxytyramine in brain tissue.

Authors:  W Kehr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  Changes in energy state and acid-base parameters of the rat brain during complete compression ischemia.

Authors:  B Ljunggren; H Schutz; B K Siesjö
Journal:  Brain Res       Date:  1974-06-20       Impact factor: 3.252

5.  Post-mortem degradation kinetics of brain norepinephrine.

Authors:  M D Faiman; M B Myers; R L Schowen
Journal:  Biochem Pharmacol       Date:  1973-09-01       Impact factor: 5.858

6.  The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay.

Authors:  C V Atack
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739
  6 in total
  11 in total

1.  3-Methoxytyramine: its suitability as an indicator of synaptic dopamine release.

Authors:  P C Waldmeier; J Lauber; W Blum; W J Richter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-01       Impact factor: 3.000

2.  Catecholamine metabolism in rat brain. The role of neutral and acidic catechol metabolites.

Authors:  H M Thiede; W Kehr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

3.  Dopamine metabolites in human brain.

Authors:  S Wilk; M Stanley
Journal:  Psychopharmacology (Berl)       Date:  1978-04-14       Impact factor: 4.530

4.  Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia.

Authors:  A Carlsson; B Winblad
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

5.  3-Methoxytyramine as an indicator of impulse-induced dopamine release in rat brain in vivo.

Authors:  W Kehr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-06       Impact factor: 3.000

6.  Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis.

Authors:  P Riederer; S Wuketich
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

7.  Alteration of acetylcholine synthesis in mouse brain cortex in mild hypoxic hypoxia.

Authors:  M Shimada
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

8.  Biochemical and functional evidence for a marked dopamine releasing action of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (NMPTP) in mouse brain.

Authors:  E Pileblad; H Nissbrandt; A Carlsson
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

9.  3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.

Authors:  C F Saller; A I Salama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-10       Impact factor: 3.000

10.  In vivo effects of the Ca2+-antagonist nimodipine on dopamine metabolism in mouse brain.

Authors:  E Pileblad; A Carlsson
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.